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ABSTRACT
The risk of an osteoporotic hip fracture is greater than the combined risks of breast
cancer, myocardial infarction and stroke, yet research shows less than 25% of women are
being screened. Post-menopause, either surgical or natural, is a risk factor for
osteoporosis. Nurse practitioners are in an excellent position to lead the way in
osteoporosis screening. This article presents findings in a recent osteoporosis screening
program in a primary care office.

Background
Osteoporosis is the leading cause of fractures in persons over 50. 1 Non-hip fractures are
responsible for 80% of fractures presenting to hospitals worldwide. 2 Only 23% of
women over age 67 suffering non-hip fragility fractures or hip fractures are evaluated and
treated for osteoporosis.3 In 2014, prevalence data studied showed 54 million Americans
50 years and older are affected by osteoporosis, (10 million with osteoporosis) and
(44million with low bone mass),equaling approximately half of the United States adult
population.4 United States Preventative Service Task Force (USPSTF) estimates by
2020 12.3 million persons 50 years or older are expected to have osteoporosis.5
Physiologically fractures occur as a result of low bone mass. Estimate annual incidence
of osteoporotic fracture in 2014 is greater than 1.5 million people with a cost estimate of
more than $17 billion dollars spent yearly on osteoporosis patients.6 Defined by the

World Health Organization, osteoporosis is the loss of bone mass and microarchitectural deterioration of bone which contributes to increased bone fragility leading to
an increased fracture rate worldwide. 7 Research shows fewer than 25 % of women are
being screened.7 This lack in care continues to place women at risk for serious, often
preventable fractures and their sequelae. Nurse practitioners, as primary care providers
have an excellent opportunity to be leaders in osteoporosis prevention.
Literature review by the USPTF in 2017 found that the risk benefit of screening for
women 65 years and older is at least moderate, and therefore women under the age of 65
who are post-menopausal, either surgical or natural, with at least one risk factor, should
also be screened additionally.8 Hadjidakis studied the effects of bone loss in relation to
the age of menopause and type of menopause, surgical versus natural.9 (Lower vertebral
bone mineral density was found in women with an early bilateral salpingo-oopherectomy
(BSO) versus a woman who had a natural menopause in ages 45-55 years old. 10Yoshida
studied this same cohort measuring the metabolic biomarker N-terminal
telopeptide (NTX ), which is found in the urine with bone turnover.11 He found there
existed significant increased NTX levels from 6 to 12 months following an
oophorectomy associated with seriously decreased bone mineral density(BMD) by as
much as 6.7% at 12 months post -op. He concluded there is a two-fold increase in lower
bone density for those women who underwent surgical menopause versus a natural one.
12 His research illustrates the seriousness of this problem , which is not given appropriate
emphasis to providers in the clinical setting .
Purpose
The goal of this program was to increase the identification of post-menopausal women
surgical or natural, between ages 30-64 by screening for those qualified for referral for a
dual absorptiometry (DXA) test scan through the use of a nationally recognized and
accepted screening tool, The Simple Calculated Osteoporosis Risk Estimation (SCORE)
risk assessment tool. 13. This program parallels the level B recommendation by the
USPSTF which recommends bone density testing in postmenopausal women under the
age of 65 who have an increased risk of osteoporosis which is determined through the use
of a formal clinical risk assessment tool. 14The USPSTF evaluated evidence and
concluded that clinical risk assessment tools including the SCORE assessment tool are
moderately accurate in identifying those at risk of osteoporosis.15
All female patients identified as post-menopausal seen in the primary care practice
between May 2019 and July 2019 were screened with the SCORE tool to determine if
they were referred for a DXA scan. The DXA scan is done to determine bone density, a
significant determinate used in the diagnosis of osteoporosis.
Identification of Osteoporosis
According to the 2018 Endocrine society guidelines, DXA scans are considered the gold
standard utilized in diagnosing osteoporosis.16The evidence states that post-menopausal
women either surgical or natural have an increased loss of bone mass in the years

immediately following the decrease in circulating estrogen.17 Currently providers
collectively have established the practice of providing bone density testing for women
over the age of 65, however the evidence clearly states that it is the ocurance of
menopause with the depletion of estrogen (occurring either natural or surgically) causing
the accelerated bone breakdown process leading to osteoporosis that should be the
sentinel event precipitating a referral for a DXA scan.18 Evidence supports the process of
identification of these at risk women needing a DXA scan to evaluate for the presence of
asymptomatic osteoporosis before the first fracture occurs.19 Research demonstrates that
the single most significant predictor of osteoporotic risk fracture prediction is BMD
which is obtained from a DXA scan. 20
The Program
Instructing the medical assistants and providers on accurate completion of the SCORE
assessment tool was accomplished in our weekly team meeting after approval for the
program was secured by appropriate administrative chain of command. Each female of
this select cohort seen in clinic for 90 consecutive days May 1st through July 1st 2019,
was screened with the SCORE tool. Upon successful completion of the SCORE screen,
each female patient identified as at risk by the tool, was referred to have a DXA scan.
Interpretation of the DXA scan results and formulating the diagnosis of osteoporosis was
done by a certified clinical densitometrist. Follow up appointments were provided to
each individual screened to review results, diagnosis, recommendations and formulate a
patient centered treatment plan. This appointment time was also used to provide patient
education of the pathology of osteoporosis as well as pharmaceutical option chosen.
The Findings
There were 53 women aged 30-64 surveyed for participation in this program, those
identified as post-menopausal(either surgical or natural ) were then screened with the
SCORE tool. Of the 28 screened ,13 scored high enough to be referred for a DXA scan.
The result of the scans was consistent with what I have been seeing in practice for the past
2 years with 13 patients identified with either low bone mass (formerly osteopenia) or
osteoporosis. This represents 55% of the cohort screened. I anticipated 50% of patients
surveyed would be identified as at risk for osteoporosis and referred for a DXA scan. This
significant finding demonstrates that osteoporosis is not just a disease process of elderly
women but of all post-menopausal women which is occurring in a much earlier time period.

Implications of Practice
The silent disease of osteoporosis steals independence from women. Exposing this disease
to the public and providers alike is the first step towards screening patients to identify those
at highest risk. Numerous metrics are now part of a routine new patient intake assessment.
Incorporating the short SCORE assessment during this process will identify those women
who are post-menopausal needing to be tested by DXA. Just like a mammogram, DXA

scan evaluation of bone health needs to secure its place in the priority of health testing.
Educating providers with this information is one of the critical links to identifying
potentially affected patients. Early diagnosis and treatment of low bone mass or
osteoporosis will reverse this condition, and prevent unnecessary fractures.
Conclusion
The nurse practitioner is the perfect health care provider to spearhead community education
programs aimed at teaching the public about this silent disease Empowering people with
knowledge strengthens their ability to be self-advocates for their health. Share the
knowledge and change a life, one at a time.
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